R
Robert A. Rosenheck
Researcher at Yale University
Publications - 993
Citations - 58354
Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.
Papers
More filters
Journal ArticleDOI
Posttraumatic stress disorder and employment in veterans participating in Veterans Health Administration Compensated Work Therapy.
TL;DR: Individuals with substance use diagnoses or who were homeless at program entry were more likely to be employed at discharge, while receipt of public support income and severe mental illness decreased the likelihood of being competitively employed.
Journal ArticleDOI
Risk of Incarceration and Other Characteristics of Iraq and Afghanistan Era Veterans in State and Federal Prisons
TL;DR: OEF/OIF/OND veterans appeared to be at lower risk of incarceration than veterans of other service eras, but those who were incarcerated had higher rates of PTSD.
Journal ArticleDOI
Factors associated with stigma among caregivers of patients with bipolar disorder in the STEP-BD study.
Jodi M. Gonzalez,Deborah A. Perlick,David J. Miklowitz,Richard Kaczynski,Melissa Hernandez,Robert A. Rosenheck,Jenifer L. Culver,Michael J. Ostacher,Charles L. Bowden +8 more
TL;DR: Mental illness stigma was found to be prevalent among caregivers of persons with bipolar disorder who have active symptoms as well as for caregivers of those who have remitted symptoms.
Journal ArticleDOI
Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
TL;DR: Minimum clinically important difference estimates from a longer-term effectiveness trial were consistent with previous efforts from shorter-term efficacy trials, and can help clinicians and researchers design future studies and interpret treatment change in future research and clinical work.
Journal ArticleDOI
Cost-effectiveness of Clozapine in Patients With High and Low Levels of Hospital Use
Robert A. Rosenheck,Joyce A. Cramer,E. R. Allan,Joseph Erdos,Linda K. Frisman,Weichun Xu,Jonathan Thomas,William G. Henderson,Dennis S. Charney +8 more
TL;DR: Substantial 1-year cost savings with clozapine are observed only among patients with very high hospital use prior to initiation of treatment while clinical benefits are more similar across groups.